Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Int J Cancer. 2014 May 28;136(1):127–137. doi: 10.1002/ijc.28973

Figure 4.

Figure 4

Comparison of thyroglobulin antibodies between in house and INOVA TgAbs ELISA assay (panel A), between in house and KRONUS RIA (panel B) and INOVA TgAbs ELISA and KRONUS RIA (panel C) in a subset of 96 sera obtained from cancer patients receiving immunotherapy. Open circles indicate sera from patients who already had thyroid autoimmunity at baseline, whereas closed squares indicate those without.

Two by two table has been inserted in each panel to indicate concordant and discordant samples.